XXII רווח נקי למניה (EPS TTM) 22nd Century

22nd Century Group (XXII) is implementing biotechnologies to minimize the harm of smoking in compliance with strict regulatory standards. Thanks to patents for low-nicotine tobacco, the company possesses exceptional pricing power. The development of applied R&D projects to stabilize VLN lines is scaling its raw material base. The current annual net income per share demonstrates profit dynamics, where the parameter has settled at -37686.67.

This indicator determines the real yield of a single share, stripped of the influence of the total emission volume. By analyzing the annual net income per share trend, an investor sees the business capitalization dynamics in real-time. The metric is calculated as the ratio of final profit to the number of securities, identifying reversal points of the fundamental trend. For 22nd Century Group (XXII), this is a critical marker of the efficiency of a painful restructuring. The transition to contract assembly should be reflected in the stabilization of this indicator.